Abstract
Background: Data on SARS-CoV-2 vaccine immunogenicity in PLWH are currently limited. Aim of the study was to investigate immunogenicity according to current CD4 T-cell count.
Methods: PLWH on ART attending a SARS-CoV-2 vaccination program, were included in a prospective immunogenicity evaluation after receiving BNT162b2 or mRNA-1273. Participants were stratified by current CD4 T-cell count (poor CD4 recovery, PCDR: <200/mm3; intermediate CD4 recovery, ICDR: 200-500/mm3; high CD4 recovery, HCDR: >500/mm3). RBD-binding IgG, SARS-CoV-2 neutralizing antibodies (nAbs) and IFN-γ release were measured. As control group, HIV-negative healthcare workers (HCWs) were used.
Findings: Among 166 PLWH, after 1 month from the booster dose, detectable RBD-binding IgG were elicited in 86.7% of PCDR, 100% of ICDR, 98.7% of HCDR, and a neutralizing titre ≥1:10 elicited in 70.0%, 88.2%, and 93.1%, respectively. Compared to HCDR, all immune response parameters were significantly lower in PCDR. After adjusting for confounders, current CD4 T-cell <200/mm3 significantly predicted a poor magnitude of anti-RDB, nAbs and IFN-γ response. As compared with HCWs, PCDR elicited a consistently reduced immunogenicity for all parameters, ICDR only a reduced RBD-binding antibody response, whereas HCDR elicited a comparable immune response for all parameters.
Conclusion: Humoral and cell-mediated immune response against SARS-CoV-2 were elicited in most of PLWH, albeit significantly poorer in those with CD4 T-cell <200/mm3 versus those with >500 cell/mm3 and HIV-negative controls. A lower RBD-binding antibody response than HCWs was also observed in PLWH with CD4 T-cell 200-500/mm3, whereas immune response elicited in PLWH with a CD4 T-cell >500/mm3 was comparable to HIV-negative population.
Keywords: 2 vaccine; AIDS; CoV; HIV; SARS; anti; immunogenicity.
【저자키워드】 HIV, SARS, AIDS, CoV, Immunogenicity., 2 vaccine, anti, 【초록키워드】 SARS-CoV-2, immune response, immunogenicity, Neutralizing antibodies, mRNA-1273, CD4, healthcare worker, SARS-CoV-2 vaccine, BNT162b2, HCWs, AIDS, mRNA, ART, Neutralizing, booster dose, parameters, SARS-CoV-2 neutralizing antibodies, PLWH, SARS-CoV-2 vaccination, SARS-CoV-2 neutralizing antibody, IFN-γ, NAb, HCW, control group, HIV-negative, NAbs, confounders, participant, titre, significantly lower, parameter, controls, CD4 T-cell, RBD-binding IgG, HCDR, predicted, significantly, detectable, receiving, reduced, were used, magnitude, comparable, elicited, were measured, stratified, cell-mediated immune, RBD-binding antibody, 【제목키워드】 SARS-CoV-2, Human, CD4, coronavirus 2, response, respiratory, T-lymphocyte, count, current, Against,